Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 23, 2023
Top Gainers Q1: AI Robot Trading - $EDTX, $CVNA, $IMGN, $AAOI & More

Top Gainers Q1: AI Robot Trading - $EDTX, $CVNA, $IMGN, $AAOI & More

AI Robots: Trading in Every Style

One of the most influential advancements in recent financial history is the rise of AI robots in stock trading. These robots, programmed with sophisticated algorithms, are creating ripples in the global financial markets, executing trades at a speed and precision that outpaces human capabilities. In the last quarter, we have seen some notable gainers, namely: $EDTX, $CVNA, $EDTXU, $IMGN, $EVLO, $AAOI, $UPST, $BVS, $AMTX, and $GSIT.

Powered by advanced machine learning and data analysis techniques, these AI trading robots have achieved an unprecedented ability to identify and capitalize on trading opportunities across a wide range of styles, including high-frequency trading, arbitrage strategies, and algorithmic trading.

One of the pivotal elements in their success is the use of volume indicators. Volume indicators, an important technical analysis tool, measure the number of shares or contracts traded in a security or an entire market during a given period. AI robots use this information to understand market liquidity, and trend strength, and to predict future price movements.

Currently, stocks like $EDTX, $CVNA, $EDTXU, $IMGN, $EVLO, $AAOI, $UPST, $BVS, $AMTX, and $GSIT are presenting a positive outlook. The AI robots have identified these stocks based on a range of factors, including strong volume indicators, suggesting high investor interest and potential for future gains.

For example, shares of $EDTX and $CVNA have shown an impressive rally in recent weeks, backed by high volumes, a clear signal of their strong investor confidence. Similarly, $IMGN, $EVLO, and $AAOI have been identified as potential winners, owing to their robust trading volumes and the AI’s complex analysis of other relevant financial indicators.

Even more fascinating is the AI's capability to adapt to different trading styles, thus presenting an impressive lineup of top gainers in the last quarter across different sectors and markets. This impressive ability to dynamically adapt based on market conditions and trending patterns makes AI-powered trading robots a game-changer in today's financial world.

AI trading robots, armed with cutting-edge technologies and advanced strategies, are revolutionizing the way we trade. They are bringing unprecedented speed, efficiency, and adaptability to the financial markets, leveraging volume indicators to seize opportunities and optimize profits. As we look toward the future, the impact of AI in trading promises to be transformative and exciting.

Related Ticker: BVS, EDTX, CVNA, EDTXU, IMGN, EVLO, AAOI, UPST, AMTX, GSIT

BVS in upward trend: 10-day moving average broke above 50-day moving average on July 06, 2026

The 10-day moving average for BVS crossed bullishly above the 50-day moving average on July 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 23, 2026. You may want to consider a long position or call options on BVS as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BVS just turned positive on June 16, 2026. Looking at past instances where BVS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

BVS moved above its 50-day moving average on July 01, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BVS advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 189 cases where BVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BVS broke above its upper Bollinger Band on July 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.153) is normal, around the industry mean (10.756). P/E Ratio (21.439) is within average values for comparable stocks, (61.593). Projected Growth (PEG Ratio) (1.134) is also within normal values, averaging (3.713). BVS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.066) is also within normal values, averaging (23.791).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.67B. The market cap for tickers in the group ranges from 1.86K to 166.57B. ABT holds the highest valuation in this group at 166.57B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -16%. LAB experienced the highest price growth at 22%, while TNON experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was -44% and the average quarterly volume growth was 21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 90
Profit Risk Rating: 94
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
BVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details
Industry
N/A
Address
4721 Emperor Boulevard
Phone
+1 919 474-6700
Employees
930
Web
https://www.bioventus.com
Interact to see
Advertisement
TSM shares have remained relatively resilient despite heightened volatility, supported by the ongoing global buildout of AI infrastructure. Investor attention has centered on capacity expansion updates and signals from major customers, particularly in high-performance computing. While execution risks remain in the near term, leadership in advanced manufacturing and packaging continues to anchor TSM’s long-term growth narrative, even as global supply chains face scrutiny.
Rivian (RIVN) is carving out a distinct position in the electric vehicle market by targeting adventure-focused consumers, commercial fleets, and long-term sustainable transportation solutions. As the EV industry moves beyond early adoption toward scalability and efficiency, Rivian is emphasizing broader product offerings, streamlined manufacturing, and software-enabled services.
Aon plc (AON) reported third-quarter 2025 revenue of $3.997 billion, representing a 7% year-over-year increase with equal organic growth. Adjusted earnings per share came in at $3.05, exceeding expectations. In late November, Moody’s reaffirmed Aon’s Baa2 credit rating and revised the outlook to positive, citing reduced leverage following the NFP acquisition.
General Motors (GM) is in the midst of a long-term transformation, evolving from a traditional automotive manufacturer into a technology-focused mobility company. By combining its global scale, manufacturing capabilities, and well-known brands, GM is accelerating its push into electric vehicles, software-defined platforms, and autonomous systems, while continuing to generate cash from its internal-combustion portfolio.
Air Products and Chemicals, Inc. (APD) entered the spotlight after announcing advanced discussions with Yara International on December 8 to collaborate on low-emission ammonia projects. While the strategic direction aligns with global decarbonization trends, uncertainty around execution and capital requirements triggered a 9.45% one-day decline in the stock.
APO shares have traded in a relatively tight range recently, consolidating near the $148 level. The stock reflects investor confidence in Apollo’s expanding asset base, record fee earnings, and disciplined execution amid renewed interest in alternative assets. Growth in retirement services through Athene continues to provide stability, helping offset volatility across private equity and credit markets.
Lockheed Martin and RTX Corporation are two of the most prominent names in the aerospace and defense industry, both positioned to benefit from heightened global security concerns and sustained U.S. military spending.
Eli Lilly and Novo Nordisk are among the most influential pharmaceutical companies in the rapidly expanding GLP-1 receptor agonist market, which targets diabetes and obesity. As competition intensifies and regulatory and pricing dynamics evolve, the divergence in their stock performance has become increasingly pronounced.
Lumentum and Ciena are leading players in the optical networking sector, positioned to capitalize on surging demand for high-speed data transmission driven by AI, cloud computing, and 5G rollouts. Their business models, however, diverge significantly: LITE focuses on specialized photonic components, while CIEN offers broader networking solutions.
As 2025 winds down, the Savings Banks sector reflects a mix of stability, innovation, and AI-driven disruption. Among the most closely watched tickers—SOFI Technologies (SOFI), Ally Financial (ALLY), and PayPal Holdings (PYPL)—investors have witnessed contrasting stories of growth, valuation, and market perception.
As 2025 comes to a close, financial markets remain dynamic, with technology and entertainment stocks capturing investor attention. Streaming platforms, in particular, are navigating content consolidation, evolving consumer preferences, and digital monetization shifts. Netflix (NFLX), Disney (DIS), and Spotify (SPOT) stand out as major players at the intersection of streaming, entertainment, and technology.
Ondas Holdings (ONDS) is a wireless technology company focused on delivering secure, long-range communications for industrial Internet of Things (IoT) and data networking applications. Its solutions are built to support mission-critical operations across sectors such as rail, energy, maritime, infrastructure, and industrial automation.
Ciena’s growth is driven by expanding offerings in optical networking, network automation software, and 5G transport infrastructure, complemented by services designed to help customers modernize and future-proof their networks. Its evolving technology portfolio addresses the rising complexity, speed, and reliability requirements of today’s communications environment.
Marathon Digital Holdings (MARA) and Riot Platforms (RIOT) are two leading companies in the Bitcoin mining industry, each operating energy-intensive infrastructure to capitalize on cryptocurrency market cycles. This comparison is especially relevant amid ongoing Bitcoin price volatility and growing interest in digital assets and AI-related infrastructure.
Roivant Sciences has delivered strong year-to-date performance, with shares up roughly 82%, driven by encouraging pipeline developments and increased investment in high-potential subsidiaries such as Immunovant.
MP Materials Corp. (MP) and USA Rare Earth, Inc. (USAR) are central to the United States’ push to establish a secure, domestic supply of rare earth elements—materials critical to electric vehicles, renewable energy, and defense technologies. As geopolitical tensions and supply chain vulnerabilities intensify, these two companies offer distinct approaches to addressing U.S. dependence on foreign sources.
SanDisk (SNDK) Corporation has emerged as one of the strongest performers in the semiconductor storage space, benefiting from its central role in AI infrastructure buildouts. The stock has risen more than fivefold from recent cycle lows, fueled by accelerating demand for high-capacity NAND flash and solid-state drives essential for data-intensive workloads.
As markets move into 2026, the outlook for SPY remains cautiously optimistic. Technical momentum, investor sentiment, and AI-driven forecasts align in favor of continued upside, assuming macroeconomic conditions remain stable and Federal Reserve policy evolves as expected.
Over the past year, the Direxion Daily Semiconductor Bull 3X Shares ETF (SOXL) has stood out as one of the market’s most volatile—and potentially rewarding—leveraged ETFs. Designed to deliver three times the daily performance of the ICE Semiconductor Index, SOXL closely tracks the heartbeat of the semiconductor industry, a sector at the core of global digital and AI transformation.